DatasetName,POLD3_S(352) POLD3_S(371) POLD3_S(413) POLD3_S(458),POLD3_S(302) POLD3_S(303) POLD3_S(307) POLD3_T(303) POLD3_T(311),POLD3_S(201) POLD3_S(317) POLD3_S(423) POLD3_T(171) POLD3_T(277) POLD3_T(411)
RM2024_Intensity D4-1___3,,,
RB2022_4_PostEndurance,,,
FSO2013_Ratio M/L normalized Rep3,,0.5881323146504098,0.47727821424531647
SR2019_MCF7_Biol_repl_3,,0.5841974833834664,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,,
SR2019_LM2_Biol_repl_1,,,
RCJD2014_15min_1,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,,
CK2022_7 16-1,,0.6114049287616928,
NJH2025_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_C,0.3354713253784175,0.6374950368489598,
RKK2015_TNF-α/basal,,,
JJ2018_Ratio H/M normalized pP2,,,
NJH2025_Sub12_MICT_Pre,,,
NJH2025_Sub7_MICT_Post,,,
DL2023_control-3,,,
ZX2022_Control Replicate 2,,0.6267619934642298,
HS2024_6_B_T3,,,
JW2015_Intensity pre1,,,
IMM2018_normalised rep. int. Empty-3,,,
AMK2021_30R_p5,,,
FSO2013_Ratio M/L normalized Rep1,,0.6164760641502538,0.46414964987431
SR2019_MDAMB231_Biol_repl_4,,0.5882396356387956,
GF2025_P2_Sph,,0.5793527980677066,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,,
NJH2025_Sub13_HIIT_Mid,,,
CP2009_Ratio M/L,,,
NJH2025_Sub7_HIIT_Post,,,
KBE2022_Log2_Ex_44_T,0.28444373429183406,0.6220624736235426,
DB2022_Intensity L2,,,
TM2022_mock.4h.C,,,
AST2020_anti-CD3.2,,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,,
HS2024_7_B_N1,,,
FSO2013_Ratio M/L normalized Rep1___1,,0.6158687373561829,0.46456567857729564
SAS2015_AZD/DMSO_Exp3,,,
RM2024_Intensity D0-2___3,,,
RM2024_Intensity D6-1,,,
RB2022_8_RecoverySprint,,,
RB2022_5_PreEndurance,,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,,
EP2017_Untreated R#4 normalized log2 ratio,,,0.45326303487085556
WZ2023_Pu_010_30min,0.3527670169775504,0.6417331933267822,0.49214642318669294
AS2011_Ratio H/L Proteins RNAi_2,,,
RB2022_4_PreStrength,,,
NJH2024_Sub4_MICT_Post,,,
AH2018_LFQ_M_1_X,0.36269000771675547,0.6564546889039622,
RB2022_8_RecoveryEndurance,,,
KBE2022_Log2_Ex_14_U,,0.6141121831931563,
FSO2013_Ratio M/L normalized Rep3___3,,,
AH2018_TMTMS3_1_C,0.4111010819401234,0.6483740893979666,
JJ2018_Ratio H/L normalized___1,,,
ZQ2022_C2,,,
RB2022_5_PreSprint,,,
PG2020_Intensity 8h_C,,0.6108733316102881,
AH2018_SILAC_MR_2_N,0.3485410811205761,0.637349104067224,
MV2014_Ratio M/L normalized A1___2 (2 min),,,
TM2022_S2.8h.B,,,
MV2014_Ratio M/H normalized B3___1 (30 min),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,,
RM2024_Intensity D6-1___2,,,
NJH2025_Sub7_MICT_Mid,,,
LY2019_P1+,,0.5982917827654619,
AS2011_Ratio H/L Proteins Inhi_2,,,
BS2014_Log2(Ratio H/L normalized),,,
UK2020_HCM_2,,,
FSO2013_Ratio H/L normalized Rep2___2,,,
EP2017_Pervanadate R#3 normalized log2 ratio,,,0.4549093876414238
RM2024_Intensity D4-3___3,,,
RB2022_5_PreStrength,,,
NJH2024_Sub4_MICT_Mid,,,
TM2022_S2.4h.A,,,
RB2022_5_PostStrength,,,
GF2025_P6_Sph,,0.5707243906780908,
RB2022_2_PreSprint,,,
ZX2022_CB treated Replicate 3,,0.625386454168804,
RM2024_Intensity D6-2___3,,,
WZ2023_Pe_025_10min,0.34849224935779877,0.639063138366053,0.49666748000159
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,,
AST2020_anti-CD3+PDL2.1,,,
KBE2022_Log2_Ex_34_U,0.2844518400348405,0.62074504704838,
WZ2023_Pu_005_10min,0.368407352721694,0.6353671663882496,0.5028534058475987
AS2011_Ratio H/L RNAi_2_1,,,
NJH2024_Sub9_HIIT_Mid,,,
CK2022_9 40-1,,0.6252183535921514,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,,
LG2023_GSK3α-1_intensity,,,
WZ2023_Pu_025_30min,0.36943137411836063,0.6373140695110255,0.4905416637782077
AH2018_SILAC_MR_2_X,0.3633387150659604,0.6519162311194602,
HS2024_4_PD_T2,,,
NJH2024_Sub4_HIIT_Pre,,,
RB2022_2_RecoverySprint,,,
AS2011_Ratio H/L Protein RNAi_1,,,
RM2024_Intensity D2-1___2,,,
CR2017_Ratio Replicate 1.4,0.32903904559822705,0.6057744735142865,
FR2021_Norm.Intensity.B,,,
RM2024_Intensity D6-2___1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,,
RB2022_5_PostSprint,,,
EJN2021_3_Rest_Basal,,,
CR2017_Ratio Replicate 1.3,0.33295852218277516,0.5985710093154637,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,,
KTGR2014_Ratio-Rapa 7 mins,,,
AMK2021_120R_p1,,,
AH2018_SILAC_3_X,0.37340061715600553,0.6344292504527453,
JJ2018_Ratio M/L normalized pP3,,,
AH2018_SILAC_M_2_N,0.3837664939850946,0.6462370602386439,
HS2024_7_PD_T2,,,
FSO2013_Ratio H/L normalized Rep1___1,,0.620664953673163,0.4793828787199366
AH2018_LFQ_1_C,,0.6519370950450041,
AS2011_Ratio H/L Normalized Inhi_1_3,,,
KBE2022_Log2_Ex_28_T,0.2925364862959322,0.6306677748661478,
HS2024_3_B_N1,,,
RM2024_Intensity D4-2___3,,,
WZ2023_Pe_025_30min,0.34886370600406447,0.6376929926493259,0.5030016585406994
CK2022_11 40-1,,0.6249899196925754,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,,
AH2018_SILAC_2_X,0.3801793424759405,0.6362948197473163,
MV2014_Ratio H/M normalized A2___2 (2 min),,,
AS2011_Ratio H/L RNAi_1_2,,,
KS2014_Intensity E15_1,,0.6563714283051488,0.4891288621422221
FSO2013_Ratio H/L normalized Rep2,,0.6186692488715128,0.48160972105047745
WZ2023_Pu_005_20min,0.36366919683749194,0.6395275859768322,0.4854496667743453
NJH2024_Sub10_MICT_Post,,,
RM2024_Intensity D2-3___1,,,
CR2017_Ratio Replicate 1.5,0.3406579823235585,0.6054966282522667,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,,
HS2024_7_B_T3,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,,
AS2011_Ratio H/L RNAi_1,,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,,
AH2018_LFQ_M_1_C,0.34525190242476644,0.6544904037119059,
NJH2025_Sub7_MICT_Pre,,,
SR2019_SKBR3_Biol_repl_2,,,
HS2024_9_B_T2,,,
KTGR2014_Ratio-AA 7 mins,,,
MV2014_Ratio L/H normalized B3___3 (5 min),,,
HS2024_3_PD_T1,,,
FSO2013_Ratio M/L normalized Rep3___2,,,
SR2019_BT549_Biol_repl_3,,,
RCJD2014_20min_mean,,,
FR2021_Norm.Intensity.H,,,
RB2022_2_PreStrength,,,
DB2022_LFQ intensity L1.2,,,
HS2024_4_B_N1,,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,,
CK2022_1 16-1,,0.6201945946680709,
CK2022_1 200-1,,0.6077759614463373,
PG2020_Intensity Mock_10h_D,,0.6012475963964554,
SR2019_MCF10A_Biol_repl_2,,0.5726737223561212,
JJ2018_Ratio M/L normalized pP2___2,,,
HS2024_6_PD_T1,,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,,
RB2022_6_RecoveryEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,,
EP2017_Mitotic R#2 normalized log2 ratio,,,0.46383042449148126
RCJD2014_5min_1,,,
RM2024_Intensity D4-1___1,,,
DL2023_24h-1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,,
TM2022_S2.4h.C,,,
SAS2015_PLX/AZD_Exp2,,,
CR2017_Ratio Replicate 3.3,0.3628344695447173,0.5946664373922326,
PG2020_Intensity 2h_C,,0.5829908313428878,
VOI2024_Veh2 di,,,
ZX2022_CB treated Replicate 2,,0.6236076160561133,
KBE2022_Log2_Ex_8_T,,0.6234555584427532,
NJH2025_Sub10_MICT_Post,,,
HS2024_6_I_T3,,,
RN2012_L11,,0.5722226200659797,
AS2011_Ratio H/L Normalized Inhi_2_2,,,
IMM2018_normalised rep. int. Empty-1,,,
HS2024_5_PD_T1,,,
AH2018_LFQ_M_2_C,0.3721202121113866,0.6499482286254828,
CK2022_3 40-1,,0.6262168295370698,
RBK2021_1260T Early,,,
NJH2024_Sub4_HIIT_Post,,,
HS2024_4_I_T1,,,
YA2020_Reporter_intensity_Cancer_No.5,0.3354055964952113,0.6195796379810355,
HH2022_Reporter intensity 8,,0.5857295279321109,
ZQ2022_N2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,,
FSO2013_Ratio H/L normalized Rep3___3,,,
AH2018_TMTMS3_2_N,0.4188662283761997,0.6432250536245165,
EJN2021_5_Rest_Basal,,,
NJH2025_Sub2_HIIT_Post,,,
NJH2025_Sub1_MICT_Post,,,
HS2024_9_B_T1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,,
JAW2011_Ratio H/L LS2_1,,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,,
NJH2024_Sub6_HIIT_Pre,,,
AH2018_SILAC_3_N,0.34730250584769495,0.6343695700834339,
YA2020_Reporter_intensity_Normal_No.1,,0.6036282374283436,
HS2024_3_B_T1,,,
JJ2018_Ratio H/L normalized___2,,,
RM2024_Intensity D0-2,,,
MV2014_Ratio M/L normalized B1___2 (5 min),,,
RB2022_7_PostStrength,,,
RB2022_1_PostEndurance,,,
CR2017_Ratio Replicate 3,0.4574506295496651,0.5949074357487673,
SR2019_Hs578T_Biol_repl_3,,,
MV2014_Ratio L/H normalized B3___1 (5 min),,,
RBK2021_1244T Early,,,
RB2022_3_PostSprint,,,
NJH2024_Sub13_MICT_Mid,,,
KTGR2014_Ratio-AA 2 mins,,,
GF2025_P7_Sph,,0.5770867847733513,
HS2024_8_I_T3,,,
CF2017_EOC 3,,,0.5221258068821464
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,,
HS2024_6_PD_T3,,,
DL2023_12h-2,,,
RM2024_Intensity D6-3___1,,,
FS2019_Ctr1,,,
WZ2023_Pu_010_20min,0.36073480496171717,0.637721522091181,0.4963393805150003
AS2011_Ratio H/L_3,,,
CK2022_1 40-1,,0.6259889070048377,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,,
CK2022_8 16-1,,0.612848644495773,
KS2014_Intensity N3,0.3661345305216851,,0.4928858925307676
RB2022_4_RecoveryEndurance,,,
RB2022_5_RecoveryEndurance,,,
JAW2011_Ratio H/L LS1a_2,,,
NJH2024_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_N,0.37548263468876897,0.6434149442949669,
FSO2013_Ratio H/M normalized Rep2,,0.608644306331942,0.47206145149368045
RAM2015_Log2 A,,0.5853775490502062,
HS2024_8_PD_T1,,,
JJ2018_Ratio H/L normalized pP2,,,
CF2017_OSE 27,,,0.4822921050633793
KS2014_Intensity E15_2,,0.6509055902007053,0.4873358785147695
BS2014_Log2(Ratio H/L protein),,,
PG2020_Intensity 8h_A,0.35227984843192867,0.6104257038647507,
HS2024_7_I_T1,,,
VOI2024_Veh3 di,,,
RKK2015_TNF-α+SC-514/basal,,,
SR2019_JIMT1_Biol_repl_1,,0.6066169223066895,
HW2015_Ratio H/L normalized Exp2,,,
HS2024_3_I_N1,,,
AH2018_SILAC_M_3_X,0.37536276941034125,0.6417247431688615,
NJH2024_Sub9_HIIT_Post,,,
AS2011_Ratio H/L RNAi_1_3,,,
GRW2016_Ratio H/L normalized SILAC 1___2,,,
NJH2025_Sub1_HIIT_Pre,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,,
NJH2024_Sub4_HIIT_Mid,,,
VOI2024_0.1uM 2 h_1 di,,,
KBE2022_Log2_Ex_6_T,0.28954095361451426,0.6171185121799813,
RM2024_Intensity D4-3___1,,,
AH2018_LFQ_4_X,,0.6336231793225143,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
RB2022_8_PostEndurance,,,
NJH2025_Sub4_MICT_Mid,,,
YP2020_Intensity C30_R1_mult_log2,,,
AST2020_anti-CD3.1,,,
NJH2025_Sub4_HIIT_Post,,,
EP2017_Untreated R#4 log2 ratio,,,0.45320619698419384
HS2024_6_B_N1,,,
KBE2022_Log2_Ex_27_T,0.27092412185409365,0.6117499794845369,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,,
VOI2024_0.1uM 24 h_1 mono,,,
AMK2021_120R_p5,,,
AS2011_Ratio H/L Proteins,,,
NJH2024_Sub7_HIIT_Post,,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,,
AS2011_Ratio H/L RNAi_2_2,,,
RB2022_7_RecoveryStrength,,,
AH2018_SILAC_IT_3_X,0.3737736751827542,0.6411654810840262,
JAW2011_Ratio H/L,,,
PG2020_Intensity 10h_C,0.3580381983810613,0.6023572159724996,
FSO2013_Ratio M/L normalized Rep2,,0.6176321690154452,0.4448320719712638
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,,
HH2022_Reporter intensity 5,,0.5952257394435606,
SR2019_HCC1954_Biol_repl_2,,0.5730779416905774,
CK2022_14 40-1,,0.6228470582869502,
RB2022_6_PreSprint,,,
NJH2025_Sub12_MICT_Mid,,,
PG2020_Intensity 4h_D,,0.6007519041446692,
NJH2025_Sub2_MICT_Post,,,
AH2018_LFQ_4_C,,0.6423965876632648,
DL2023_control-1,,,
AR2021_ALG 10 μM,,0.6146185968514092,
JAW2011_Ratio H/L LS2_2,,,
AH2018_SILAC_IT_3_N,0.34410480371078184,0.6378072940140128,
EJN2021_4_Rest_Ins,,,
RN2012_H05,,0.6116824837879454,
NJH2024_Sub7_HIIT_Mid,,,
GF2025_P2_Adh,,0.6144919790540008,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,,
RB2022_8_PostSprint,,,
EJN2021_1_Rest_Ins,,,
HH2022_Reporter intensity 3,,0.6117966407311896,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,,
AH2018_SILAC_IT_1_C,0.33640865175627255,0.6389861070357712,
JW2021_After_3,,,
GF2025_P8_Sph,,0.5615480794677696,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,,
JJ2018_Ratio M/L normalized pP2___1,,,
AH2018_SILAC_2_N,0.3818920126450579,0.6381870593675096,
CK2022_11 200-1,,0.607074702398462,
CK2022_12 200-1,,0.6101129776782146,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,,
RM2024_Intensity D2-1___3,,,
NJH2024_Sub1_MICT_Pre,,,
HH2022_Reporter intensity 9,,0.6657493856785267,
WZ2023_Su_010_20min,0.3658919075794459,0.6386699356773435,0.48115102367961743
AH2018_TMTMS2_2_N,0.41869889367008084,0.6499990884221297,
NJH2024_Sub13_MICT_Pre,,,
KBE2022_Log2_Ex_41_U,0.27092412185409365,0.6291806990651312,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,,
AH2018_TMTMS3_Pool,0.3993215801404568,0.6360516379870348,
KS2014_Intensity N4,0.354770416389211,0.6523565056358078,0.5126149720909993
NJH2024_Sub1_HIIT_Post,,,
MM2018_Ratio H/L replicate2,,0.6039708579275338,
RM2024_Intensity D4-2___2,,,
NJH2024_Sub13_HIIT_Pre,,,
CF2017_OSE 26,,,0.49685722929745224
CK2022_14 200-1,,0.6075163007346197,
SR2019_Hs578T_Biol_repl_1,,,
RB2022_7_PostSprint,,,
TM2022_mock.4h.A,,,
NJH2025_Sub12_HIIT_Pre,,,
AH2018_TMTMS3_1_N,0.4050973228794451,0.6279079941084796,
AST2020_anti-CD3+PDL2.2,,,
PG2020_Intensity Mock_10h_A,,0.6072665165457456,
JW2021_After_2,,,
NJH2024_Sub2_MICT_Post,,,
EJN2021_2_Rest_Ins,,,
SR2019_LM2_Biol_repl_4,,,
CP2009_Ratio H/M,,,
JAW2011_Ratio H/L HS,,,
CK2022_13 16-1,,0.6163690206181428,
GF2025_P1_Adh,,0.5903740239037576,
GF2025_P1_Sph,,0.586534230301682,
EJN2021_5_Ex_Basal,,,
HS2024_7_I_T3,,,
JJ2018_Ratio H/L normalized pP2___2,,,
WZ2023_Pe_010_10min,0.3642899510476839,0.6333127464059134,0.5185479412849502
CF2017_EOC 1,,,0.5138476826031532
CK2022_3 200-1,,0.60761386711393,
AH2018_LFQ_IT_3_C,0.3587055429507082,0.6352232124341329,
SR2019_Hs578T_Biol_repl_2,,,
NJH2024_Sub12_HIIT_Post,,,
JJ2018_Ratio H/L normalized pP1___2,,,
MV2014_Ratio H/L normalized A1___2 (10 min),,,
NJH2024_Sub10_MICT_Mid,,,
NJH2024_Sub13_MICT_Post,,,
BS2014_Log2(Ratio H/L normalized Rep_1),,,
RB2022_3_RecoverySprint,,,
NJH2025_Sub1_HIIT_Mid,,,
RCJD2014_20min_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,,
HS2024_6_PD_T2,,,
HS2024_5_B_T1,,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,,
DL2023_12h-3,,,
SR2019_MDAMB231_Biol_repl_2,,0.5922661171226717,
HS2024_3_B_T2,,,
RB2022_6_PreStrength,,,
CK2022_2 40-1,,0.6260464419084365,
RB2022_1_PostSprint,,,
CK2022_4 200-1,,0.6054398465915842,
JW2021_Before_2,,,
TM2022_S2.12h.A,,,
MV2014_Ratio L/M normalized B2___2 (30 min),,,
CK2022_5 16-1,,0.612717518801808,
AR2021_ALG 1 μM,,0.5947087318691665,
HS2024_4_B_T1,,,
MV2014_Ratio M/H normalized A3___1 (10 min),,,
SR2019_BT549_Biol_repl_4,,,
EJN2021_1_Rest_Basal,,,
NJH2025_Sub8_MICT_Post,,,
RCJD2014_5min_3,,,
CR2017_Ratio Replicate 3.2,0.45727896849309924,0.588859454999417,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,,
GF2025_P7_Adh,,0.5749741151793902,
CK2022_9 16-1,,0.6204998728192892,
NJH2024_Sub6_HIIT_Post,,,
AMK2021_30R_p3,,,
AS2011_Ratio H/L Normalized RNAi_2,,,
RM2024_Intensity D0-2___2,,,
KS2014_Intensity pY_N4,,0.5772763402194978,0.4978507484263229
CK2022_13 200-1,,0.6092628006273025,
AS2011_Ratio H/L Normalized_2,,,
PG2020_Intensity 6h_D,,0.6100282839723465,
CK2022_16 16-1,,0.618229198553937,
FS2019_db/db3,,,
CK2022_15 40-1,,0.6237175122047617,
NJH2024_Sub9_MICT_Pre,,,
BS2014_Log2(Ratio H/L unmodified peptide),,,
WZ2023_Su_005_10min,0.36689402988125874,0.6289145852831596,0.48025239938077474
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,,
KBE2022_Log2_Ex_41_T,0.27940878944765146,0.6490547334752145,
AMK2021_Ctrl_p1,,,
AH2018_LFQ_IT_3_X,0.3801733547665172,0.6363320691283862,
HS2024_5_PD_T3,,,
AH2018_TMTMS3_3_X,0.39680076144860693,0.6329810684441667,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,,
KBE2022_Log2_Ex_40_U,,0.6402356534021634,
AH2018_LFQ_M_1_N,,0.6487286149873052,
KBE2022_Log2_Ex_27_U,0.27092412185409365,0.609862890037648,
HW2015_Ratio M/L normalized Exp3,,,
RKK2015_TNF-α/IKKb(K44M),,,
AH2018_SILAC_M_1_N,0.37730621934775127,0.6422659509221009,
HW2015_Ratio M/L normalized Exp1,,,
RB2022_5_RecoveryStrength,,,
YP2020_Intensity P10_R1_mult_log2,,,
RB2022_7_PreStrength,,,
YA2020_Reporter_intensity_Normal_No.4,,0.599731150054809,
NJH2025_Sub13_HIIT_Pre,,,
PG2020_Intensity CT_D,,0.5886377218786161,
NJH2025_Sub9_MICT_Post,,,
VOI2024_Veh1 mono,,,
CK2022_12 16-1,,0.6206623295725796,
RN2012_L13,,0.5909182404565289,
LG2023_Control-1_intensity,,,
RM2024_Intensity D6-3___2,,,
KBE2022_Log2_Ex_8_U,,0.605837137746714,
SR2019_SKBR3_Biol_repl_3,,0.5665737724667343,
NJH2024_Sub1_MICT_Post,,,
HS2024_3_I_T2,,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,,
RM2024_Intensity D0-3___3,,,
HS2024_6_I_T2,,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,,
AS2011_Ratio H/L Protein Inhi_1,,,
FSO2013_Ratio H/M normalized Rep2___1,,0.6107754088292543,0.47516953952711516
GRW2016_Ratio M/L normalized SILAC 5a___2,,,
CK2022_10 40-1,,0.6245822237298465,
NJH2024_Sub12_HIIT_Pre,,,
NJH2024_Sub8_MICT_Pre,,,
RM2024_Intensity D0-1___1,,,
LY2019_P3+,,0.5819468704168959,
HH2022_Reporter intensity 6,,0.6419189210479226,
RB2022_2_RecoveryStrength,,,
KTGR2014_Ratio-AA 15 mins,,,
AS2011_Ratio H/L Normalized RNAi_2_2,,,
KS2014_Intensity pY_N3,,0.5451682596857665,0.4971085507551147
MV2014_Ratio H/L normalized B1___2 (30 min),,,
LY2019_P5-,,0.6015561949863981,
HW2015_Ratio M/L normalized Exp2,,,
SR2019_HCC1419_Biol_repl_1,,,
AH2018_TMTMS2_3_X,0.42017394702606714,0.6544260257863252,
GF2025_P3_Adh,,0.5734706544944411,
SR2019_JIMT1_Biol_repl_2,,0.611781062261038,
AH2018_TMTMS2_1_C,0.40740006855269284,0.6471014267928207,
RM2024_Intensity D0-1___2,,,
LY2019_P4+,,0.6050635400527169,
KBE2022_Log2_Ex_19_U,,0.6249478386311735,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,,
RB2022_4_PostStrength,,,
LG2023_GSK3α-3_intensity,,,
YA2020_Reporter_intensity_Cancer_No.1,,0.6194197640752404,
AST2020_Control,,,
JAW2011_Ratio H/L LS1a,,,
RCJD2014_5min_mean,,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,,
NJH2025_Sub1_MICT_Mid,,,
TM2022_S2.12h.C,,,
NJH2025_Sub9_MICT_Mid,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,,
AS2011_Ratio H/L Normalized Inhi_1_2,,,
FSO2013_Ratio M/L normalized Rep2___1,,0.6167677959030924,0.4450420427224675
LG2023_Control-2_intensity,,,
NJH2024_Sub8_HIIT_Pre,,,
KS2014_Intensity pY_N2,,,0.4947812196002934
RB2022_5_RecoverySprint,,,
RB2022_7_RecoverySprint,,,
YA2020_Reporter_intensity_Normal_No.3,,0.5979117812744312,
HS2024_8_B_T2,,,
AH2018_LFQ_1_X,0.3419830370559819,0.6532253387231933,
RM2024_Intensity D6-1___1,,,
RCJD2014_10min_2,,,
FR2021_Norm.Intensity.M,,,
RM2024_Intensity D0-3___1,,,
KS2014_Intensity N2,,0.6402306775806574,0.5119438764655888
HH2022_Reporter intensity 1,,0.6102174413255241,
HH2022_Reporter intensity 2,,0.6111441166197968,
RM2024_Intensity D6-2___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,,
RM2024_Intensity D2-3___2,,,
YA2020_Reporter_intensity_Normal_No.5,,0.6044009531573902,
SR2019_MCF7_Biol_repl_1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,,
HS2024_8_B_T1,,,
NJH2025_Sub6_HIIT_Pre,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,,
EP2017_Untreated R#2 log2 ratio,,,0.48451309829092265
SR2019_LM2_Biol_repl_3,,,
RB2022_4_RecoveryStrength,,,
CR2017_Ratio Replicate 2,0.3500589141733011,0.5926560366823981,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,,
FSO2013_Ratio H/M normalized Rep3,,0.5861599998232891,0.4725739480817091
AR2021_KD 72h,,0.6091654122812347,
MV2014_Ratio H/M normalized B2___3 (5 min),,,
KBE2022_Log2_Ex_18_U,0.27092412185409365,0.6193726248835364,
AS2011_Ratio H/L Inhi_1_1,,,
NJH2024_Sub8_MICT_Post,,,
AH2018_TMTMS3_3_C,0.40626793414001455,0.6368761138482085,
KBE2022_Log2_Ex_9_U,0.28430284253301763,0.630982164397138,
AH2018_SILAC_M_3_N,0.35118498226001416,0.6414362047799418,
KBE2022_Log2_Ex_13_T,,0.6373819532467453,
RM2024_Intensity D0-3,,,
SR2019_SKBR3_Biol_repl_1,,,
PG2020_Intensity Mock_10h_C,,0.6043612786698958,
CF2017_OSE 29,,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,,
NJH2025_Sub1_HIIT_Post,,,
DL2023_24h-2,,,
HS2024_7_B_N2,,,
PG2020_Intensity 10h_A,0.35195436567165983,0.5862220615145362,
RN2012_L12,,0.5712968991958308,
MV2014_Ratio M/L normalized B1___3 (5 min),,,
NJH2024_Sub8_MICT_Mid,,,
AH2018_LFQ_IT_4_C,0.32489233567804504,0.6323754230506092,
SAS2015_PLX/AZD_Exp1,,,
FR2021_Norm.Intensity.A,,,
FSO2013_Ratio H/M normalized Rep1___1,,0.6145258699901074,0.48355236438564403
JW2015_Intensity cap2,,,
BS2014_Log2(Ratio H/L normalized Rep_2),,,
NJH2024_Sub6_MICT_Post,,,
CK2022_8 40-1,,0.6170221008085981,
RB2022_7_RecoveryEndurance,,,
NJH2025_Sub12_HIIT_Post,,,
EJN2021_4_Ex_Basal,,,
TM2022_S2.12h.B,,,
RN2012_L15,,0.5972428135080168,
KS2014_Intensity pY_PV3,,0.5778483234541129,
TM2022_S2.4h.B,,,
PG2020_Intensity 4h_A,,0.605147597666341,
FSO2013_Ratio H/M normalized Rep2___2,,,
TM2022_mock.4h.B,,,
KBE2022_Log2_Ex_24_U,0.27092412185409365,0.6151167624078704,
NJH2025_Sub13_MICT_Mid,,,
KS2014_Intensity C3,,0.6560455736050502,0.45910084784002486
RB2022_1_PreSprint,,,
HS2024_4_I_N1,,,
CK2022_7 200-1,,0.5932540174195433,
CK2022_5 200-1,,0.5959391563541298,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,,
FSO2013_Ratio H/L normalized Rep2___1,,0.6193615903026715,0.4818475214630811
NJH2024_Sub10_HIIT_Mid,,,
RB2022_2_PostEndurance,,,
AH2018_LFQ_2_C,0.3576587903366358,0.6473434181310301,
AH2018_SILAC_MR_1_X,0.34339805630577414,0.6519075819764915,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,,
IMM2018_normalised rep. int. Empty-2,,,
RM2024_Intensity D4-1,,,
KBE2022_Log2_Ex_25_U,0.27092412185409365,0.6238150480962441,
AH2018_SILAC_3_C,0.324872336360115,0.6324968540990608,
EJN2021_5_Rest_Ins,,,
VOI2024_0.1uM 24 h_3 di,,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,,
DB2022_LFQ intensity L2.1,,,
FSO2013_Ratio H/M normalized Rep1,,0.6137482877152006,0.481364663049459
CK2022_4 16-1,,0.6196712998469789,
AS2011_Ratio H/L,,,
SR2019_MCF7_Biol_repl_4,,,
EJN2021_2_Ex_Ins,,,
AS2011_Ratio H/L Inhi_2_3,,,
JAW2011_Ratio H/L LS1a_1,,,
AH2018_LFQ_1_N,,0.6465174542760931,
SAS2015_PLX/DMSO_Exp1,,,
SFR2015_HL_log2_ratio_avg_c,0.43061319131781683,0.5832421455459528,
JJ2018_Ratio M/L normalized pP2,,,
NJH2024_Sub7_MICT_Mid,,,
PG2020_Intensity 6h_B,,0.6110737763743741,
FSO2013_Ratio H/L normalized Rep3,,0.589029518164077,0.490732072895315
GRW2016_Ratio H/L normalized SILAC 2___2,,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,,
JJ2018_Ratio M/L normalized,,,
KTGR2014_Ratio-AA 30 mins,,,
JW2021_After_1,,,
NJH2025_Sub2_MICT_Mid,,,
HS2024_6_B_N2,,,
KBE2022_Log2_Ex_9_T,0.2882093049632533,0.6353993179983545,
AH2018_SILAC_IT_2_N,0.36886940663778145,0.6378121860557423,
AH2018_SILAC_IT_1_X,0.35236274565735903,0.6382629772767643,
HW2015_Ratio H/L normalized Exp3,,,
HS2024_7_PD_T1,,,
UK2020_UA_2,,,
RM2024_Intensity D2-1___1,,,
GF2025_P10_Sph,,0.5726306424694678,
WZ2023_Pe_025_20min,0.34615128451153526,0.6401138067905043,0.4966757081662759
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,,
AH2018_LFQ_2_N,0.3814363379950835,0.6519134401342463,
HS2024_4_I_N2,,,
AH2018_TMTMS2_3_N,0.41457290925210477,0.6585468574809381,
RN2012_H06,,0.5825899432693231,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
HS2024_4_PD_T3,,,
WZ2023_Su_005_30min,0.36104112100392577,0.6399097376620507,0.48756590866082955
SR2019_HCC1419_Biol_repl_4,,0.585677363444642,
JJ2018_Ratio H/M normalized___2,,,
SR2019_JIMT1_Biol_repl_3,,0.5989255900311836,
AS2011_Ratio H/L Protein,,,
UK2020_HCM_3,,,
NJH2024_Sub10_HIIT_Post,,,
CR2017_Ratio Replicate 3.1,0.45246126658322483,0.6061032482281293,
WZ2023_Su_025_10min,0.36365294347870836,0.6392563627072383,0.49653666790838075
AH2018_LFQ_IT_4_X,0.3734445627092817,0.6343009549200103,
CP2009_Ratio H/L,,,
VOI2024_0.1uM 24 h_3 mono,,,
RB2022_4_RecoverySprint,,,
RM2024_Intensity D6-3,,,
WZ2023_Su_005_20min,0.3762622948698251,0.6372448212677402,0.4762414631854736
CW2012_10 µM Gef/control Experiment 1 Replicate B,,,
SFR2015_HL_log2_ratio_avg_a,0.4099350169443051,0.5739966775967469,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,,
RB2022_1_PreEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,,
LG2023_GSK3α-2_intensity,,,
EP2017_Pervanadate R#1 log2 ratio,,,0.4451137593399042
NJH2025_Sub6_HIIT_Post,,,
RB2022_6_RecoverySprint,,,
KS2014_Intensity,0.3709936015098471,0.6594209997959507,0.5069981008266123
MV2014_Ratio H/M normalized A2___1 (2 min),,,
PG2020_Intensity 8h_D,0.33838662631770366,0.6175037279121909,
LY2019_P7+,,0.5923980792535728,
EP2017_Untreated R#1 normalized log2 ratio,,,0.5360293533766851
RN2012_L10,,0.5927790522846813,
PG2020_Intensity 4h_C,,0.6023735645686081,
EP2017_Mitotic R#3 normalized log2 ratio,,,0.49014502580751856
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,,
DB2022_LFQ intensity L1,,,
KBE2022_Log2_Ex_24_T,0.27092412185409365,0.6215774263528664,
RB2022_8_PostStrength,,,
AH2018_SILAC_IT_2_X,0.37210903404014395,0.639337204159135,
HS2024_4_B_T3,,,
NJH2024_Sub2_HIIT_Post,,,
HS2024_8_B_N2,,,
NJH2025_Sub8_HIIT_Pre,,,
JJ2018_Ratio H/L normalized pP2___1,,,
HS2024_8_I_T2,,,
KBE2022_Log2_Ex_6_U,0.27092412185409365,0.6106586276542572,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,,
CR2017_Ratio Replicate 1.1,0.3481711720026014,0.5935854305172106,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,,
MV2014_Ratio M/H normalized B3___2 (30 min),,,
CK2022_16 200-1,,0.6089268370623988,
VOI2024_0.1uM 2 h_3 di,,,
EP2017_Mitotic R#1 normalized log2 ratio,,,0.4874478700124339
GF2025_P9_Sph,,0.5834439040571688,
CK2022_6 200-1,,0.5944888882813147,
NJH2024_Sub7_MICT_Post,,,
AH2018_TMTMS3_2_X,0.39827260049582597,0.6338888243359891,
NJH2024_Sub8_HIIT_Post,,,
DB2022_LFQ intensity R1,,,
JW2015_Intensity cap3,,,
SR2019_HCC1954_Biol_repl_1,,0.5748443774486262,
HS2024_4_I_T2,,,
NJH2024_Sub2_MICT_Mid,,,
VOI2024_0.1uM 2 h_2 mono,,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,,
HS2024_4_PD_T1,,,
SAS2015_AZD/DMSO_Exp1,,,
NJH2024_Sub1_MICT_Mid,,,
IMM2018_normalised rep. int. CDK5L-3,,,
HS2024_3_B_T3,,,
MV2014_Ratio L/H normalized A3___2 (2 min),,,
NJH2025_Sub13_MICT_Pre,,,
SR2019_MDAMB231_Biol_repl_3,,0.5915211875876601,
GRW2016_Ratio H/L normalized SILAC 4___1,,,
MM2018_Ratio H/L replicate1,,0.5998290702321099,
PG2020_Intensity 2h_D,,0.5969550962812781,
EP2017_Untreated R#3 normalized log2 ratio,,,0.5048066193318581
MV2014_Ratio M/H normalized A3___3 (10 min),,,
NJH2024_Sub7_HIIT_Pre,,,
JAW2011_Ratio H/L LS2,,,
CK2022_8 200-1,,0.593869267378417,
KS2014_Intensity pY_C4,,0.5926388803866798,
CR2017_Ratio Replicate 3.5,0.350547532613414,0.5946928642624059,
RB2022_7_PostEndurance,,,
NJH2025_Sub4_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,,
TM2022_mock.12h.A,,,
JJ2018_Ratio H/L normalized pP1,,,
EP2017_Pervanadate R#2 normalized log2 ratio,,,0.44272722157975547
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,,
KS2014_Intensity pY_E5_4,,0.5917088314687173,
RM2024_Intensity D4-3___2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,,
AH2018_SILAC_2_C,0.3586204235788737,0.6352484081176625,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
HS2024_7_I_N1,,,
KBE2022_Log2_Ex_29_T,0.2935175697030356,0.6333445528340509,
HS2024_7_I_T2,,,
AS2011_Ratio H/L Normalized RNAi_2_3,,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,,
HS2024_6_B_T2,,,
AMK2021_45I_p5,,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,,
SAS2015_PLX/DMSO_Exp2,,,
EJN2021_1_Ex_Basal,,,
FR2021_Intensity.M,,,
RB2022_2_PostSprint,,,
AH2018_SILAC_MR_3_N,0.3515839225819808,0.6487135042924119,
MV2014_Ratio H/L normalized B1___3 (30 min),,,
CF2017_FTE 13,,,0.5102908609141307
PG2020_Intensity CT_C,,0.5801640785617572,
ZCP2016_Ratio H/L Rep 1,,,
FS2019_db/db2,,,
KS2014_Intensity pY_PV4,,0.5826599209303265,
KBE2022_Log2_Ex_39_U,0.27092412185409365,0.6248311433093271,
EP2017_Untreated R#3 log2 ratio,,,0.5049180472565314
RB2022_2_PostStrength,,,
AS2011_Ratio H/L Normalized_1,,,
MV2014_Ratio M/H normalized A3___2 (10 min),,,
CR2017_Ratio Replicate 3.4,0.3632883225313776,0.5846417309496917,
HS2024_8_PD_T2,,,
FS2019_Ctr2,,,
RB2022_6_PreEndurance,,,
FR2021_Norm.Intensity.G,,,
NJH2025_Sub9_HIIT_Post,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,,
RM2024_Intensity D4-3,,,
HS2024_8_B_N1,,,
NJH2025_Sub10_MICT_Mid,,,
KBE2022_Log2_Ex_15_U,0.3020961386349067,0.6145217870509199,
AS2011_Ratio H/L Normalized Inhi_2,,,
RKK2015_TNF-α/SC-514,,,
RB2022_3_PreSprint,,,
CR2017_Ratio Replicate 2.3,0.3970897128030826,0.5892849295936033,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,,
GF2025_P4_Adh,,0.5717911600421229,
YA2020_Reporter_intensity_Normal_No.2,0.3077820377714642,0.6018996661260496,
YP2020_Intensity P30_R2_mult_log2,,,
NJH2025_Sub13_MICT_Post,,,
HS2024_4_B_N2,,,
HS2024_3_PD_T3,,,
AMK2021_120R_p3,,,
MV2014_Ratio L/H normalized A3___3 (2 min),,,
NJH2025_Sub10_HIIT_Pre,,,
FR2021_Intensity.G,,,
RAM2015_Log2 C,,,
AS2011_Ratio H/L Proteins Inhi_1,,,
FSO2013_Ratio H/M normalized Rep1___3,,,
AH2018_LFQ_M_2_N,0.3909815608589134,0.6547706749197808,
MV2014_Ratio M/L normalized A1___3 (2 min),,,
KBE2022_Log2_Ex_40_T,,0.636287682690978,
CK2022_2 16-1,,0.6214531607927571,
RAM2015_Log2 B,,0.5925764785487105,
YP2020_Intensity C10_R1_mult_log2,,,
FSO2013_Ratio M/L normalized Rep1___2,,,
NJH2025_Sub8_MICT_Pre,,,
EJN2021_4_Rest_Basal,,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,,
JJ2018_Ratio H/M normalized pP3___1,,,
VOI2024_Veh2 mono,,,
HS2024_6_B_T1,,,
UK2020_HCM_5,,,
NJH2025_Sub10_HIIT_Post,,,
VOI2024_0.1uM 2 h_3 mono,,,
JW2015_Intensity pre3,,,
AS2011_Ratio H/L Normalized Inhi_2_1,,,
DL2023_24h-3,,,
HS2024_7_PD_T3,,,
PG2020_Intensity Mock_10h_B,,0.5980515002929614,
WZ2023_Su_025_30min,0.36966298516156837,0.6372775740183118,0.4823189889682557
AH2018_LFQ_4_N,0.3551462439345247,0.6461725484201539,
CR2017_Ratio Replicate 1.2,0.37708934195176125,0.6017942398655212,
AS2011_Ratio H/L Normalized by Proteins,,,
RB2022_6_RecoveryStrength,,,
HS2024_8_I_N1,,,
AMK2021_Ctrl_p3,,,
AS2011_Ratio H/L Protein Inhi_2,,,
HH2022_Reporter intensity 7,,0.6275173180750114,
AH2018_SILAC_M_1_X,0.36876092225553414,0.6406397467992841,
RB2022_7_PreEndurance,,,
VOI2024_0.1uM 24 h_2 di,,,
DL2023_control-2,,,
LY2019_P6+,,0.5873202442440679,
DB2022_LFQ intensity R2,,,
GF2025_P6_Adh,,0.6218750275609592,
VOI2024_Veh1 di,,,
AS2011_Ratio H/L RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,,
VOI2024_Veh3 mono,,,
HS2024_5_I_T2,,,
NJH2025_Sub7_HIIT_Mid,,,
MV2014_Ratio H/L normalized B1___1 (30 min),,,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,,
RB2022_6_PostSprint,,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,,
AS2011_Ratio H/L Inhi_1,,,
AS2011_Ratio H/L Normalized RNAi_1_2,,,
AH2018_TMTMS3_2_C,0.3904805057266821,0.6374059670041416,
SR2019_Hs578T_Biol_repl_4,,,
RB2022_8_PreStrength,,,
KS2014_Intensity C5,,0.6734723856460221,0.48343485968989586
RM2024_Intensity D0-1,,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,,
YP2020_Intensity P30_R1_mult_log2,,,
NJH2025_Sub2_HIIT_Pre,,,
RB2022_3_RecoveryEndurance,,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,,
GF2025_P9_Adh,,0.6266649188420251,
RB2022_3_PostStrength,,,
TM2022_S2.8h.A,,,
AS2011_Ratio H/L RNAi_1_1,,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,,
NJH2025_Sub2_MICT_Pre,,,
MV2014_Ratio L/M normalized A2___3 (10 min),,,
MV2014_Ratio H/M normalized A2___3 (2 min),,,
HS2024_4_B_T2,,,
SR2019_BT549_Biol_repl_1,,0.5849482117098425,
AH2018_LFQ_M_4_N,0.3704356533840627,0.6491949530222414,
NJH2024_Sub8_HIIT_Mid,,,
PG2020_Intensity 8h_B,,0.611651549212707,
AH2018_LFQ_2_X,0.37563996056021665,0.6520473928561625,
PG2020_Intensity 2h_B,,0.5822814484700023,
AS2011_Ratio H/L Proteins RNAi_1,,,
RB2022_4_PostSprint,,,
KS2014_Intensity E15_3,,0.6503369130373007,0.4556998887364612
GF2025_P3_Sph,,0.5867250180388177,
DB2022_LFQ intensity L2,,,
MV2014_Ratio H/L normalized A1___1 (10 min),,,
AH2018_SILAC_1_C,0.3354602276071844,0.6375659403600635,
NJH2024_Sub1_HIIT_Pre,,,
FSO2013_Ratio M/L normalized Rep2___2,,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,,
AS2011_Ratio H/L RNAi_2_3,,,
AH2018_SILAC_IT_1_N,0.316104003870447,0.6361801393582341,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,,
RB2022_4_PreEndurance,,,
JJ2018_Ratio M/L normalized pP1,,,
CR2017_Ratio Replicate 2.4,0.3896555430257793,0.5907898591087888,
ZQ2022_N1,,,
LY2019_P6-,,0.5983221270318712,
RM2024_Intensity D2-3,,,
UK2020_HCM_1,,,
JW2015_Intensity pre2,,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,,
RM2024_Intensity D2-1,,,
NJH2025_Sub12_MICT_Post,,,
MV2014_Ratio H/M normalized B2___2 (5 min),,,
RN2012_L14,,0.5714384811685037,
AH2018_LFQ_3_N,0.35805852865480087,0.6522899628052661,
RKK2015_TNF-α/IKKb,,,
SFR2015_HL_log2_ratio_std_b,0.39760646898838725,0.5925310762807479,
UK2020_UA_1,,,
KBE2022_Log2_Ex_13_U,,0.6144741536564592,
AS2011_Ratio H/L Normalized Inhi_1,,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,,
RB2022_1_RecoverySprint,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,,
JJ2018_Ratio H/L normalized pP3,,,
CK2022_7 40-1,,0.6167992255149514,
AS2011_Ratio H/L Inhi_1_3,,,
NJH2025_Sub10_HIIT_Mid,,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,,
JAW2011_Ratio H/L LS1b_1,,,
PG2020_Intensity 4h_B,,0.5921749794481391,
SR2019_BT549_Biol_repl_2,,0.5770362659039503,
RM2024_Intensity D4-2,,,
DB2022_LFQ intensity R2.2,,,
JJ2018_Ratio H/L normalized,,,
RB2022_5_PostEndurance,,,
HS2024_5_PD_T2,,,
WZ2023_Su_025_20min,0.365220990098221,0.6351036814713383,0.4824629683179171
RM2024_Intensity D2-2___1,,,
IMM2018_normalised rep. int. CDK5L-2,,,
LY2019_P8-,,0.5826014003661386,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,,
FSO2013_Ratio H/L normalized Rep1,,0.6187007795128382,0.476844686623282
NJH2024_Sub2_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,,
CK2022_13 40-1,,0.6243499664713783,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,,
RN2012_H02,,0.5859031236048388,
PG2020_Intensity 10h_D,0.36944886030317275,0.5785493516959717,
RB2022_8_PreEndurance,,,
HS2024_3_B_N2,,,
EJN2021_4_Ex_Ins,,,
AS2011_Ratio H/L Normalized by Protein,,,
EJN2021_1_Ex_Ins,,,
EP2017_Pervanadate R#3 log2 ratio,,,0.4552553678346743
FSO2013_Ratio M/L normalized Rep1___3,,,
NJH2025_Sub4_HIIT_Mid,,,
RCJD2014_5min_2,,,
RB2022_6_PostStrength,,,
AH2018_SILAC_MR_3_C,0.365690818786259,0.6483072097346774,
AH2018_LFQ_M_4_C,,0.6458552753413184,
NJH2024_Sub4_MICT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_1_1,,,
DL2023_12h-1,,,
MV2014_Ratio L/M normalized B2___1 (30 min),,,
DB2022_LFQ intensity L1.1,,,
NJH2025_Sub6_MICT_Pre,,,
NJH2025_Sub6_MICT_Post,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,,
RN2012_H04,,0.6068492949464511,
CK2022_6 40-1,,0.6174291536822462,
DB2022_LFQ intensity R2.1,,,
KBE2022_Log2_Ex_42_U,0.27092412185409365,0.6214188024706683,
LY2019_P3-,,0.5702513428853233,
FR2021_Intensity.A,,,
EJN2021_3_Ex_Ins,,,
MV2014_Ratio M/L normalized A1___1 (2 min),,,
WZ2023_Pe_005_30min,0.35132868741320167,0.6405879852193426,0.5011633189490567
HS2024_8_PD_T3,,,
EJN2021_3_Ex_Basal,,,
AST2020_Control.1,,,
JW2015_Intensity cap1,,,
PG2020_Intensity CT_A,,0.5894282082371837,
FS2019_Ctr3,,,
WZ2023_Pu_025_20min,0.35745084822724726,0.6410556183155637,0.49290894465957463
NJH2025_Sub4_MICT_Post,,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,,
GF2025_P10_Adh,,0.5689761596264559,
RB2022_1_RecoveryStrength,,,
SR2019_HCC1954_Biol_repl_4,,,
FR2021_Norm.Intensity.N,,,
HS2024_5_B_N1,,,
FSO2013_Ratio H/M normalized Rep3___3,,,
AH2018_TMTMS2_2_C,0.41305616156963265,0.6520955925081005,
RB2022_4_PreSprint,,,
DB2022_Intensity R2,,,
AH2018_TMTMS2_Pool,0.399408138808634,0.6364975558580289,
HS2024_8_I_N2,,,
RB2022_3_RecoveryStrength,,,
NJH2024_Sub6_HIIT_Mid,,,
AH2018_SILAC_M_1_C,0.3445448009229128,0.6381860770302042,
LY2019_P8+,,0.5794201921034381,
RB2022_2_RecoveryEndurance,,,
JJ2018_Ratio H/M normalized pP2___1,,,
JAW2011_Ratio H/L HS_1,,,
RB2022_3_PostEndurance,,,
KS2014_Intensity pY_PV1,,0.6008016723635743,
JAW2011_Ratio H/L LS1b_2,,,
SR2019_MCF7_Biol_repl_2,,0.5983478037368004,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,,
AS2011_Ratio H/L Normalized RNAi_1_1,,,
AH2018_LFQ_M_4_X,,0.6373733353435103,
NJH2024_Sub6_MICT_Pre,,,
JJ2018_Ratio M/L normalized pP1___2,,,
YP2020_Intensity C30_R2_mult_log2,,,
NJH2024_Sub9_HIIT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_2_3,,,
RM2024_Intensity D0-1___3,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,,
KBE2022_Log2_Ex_28_U,0.28006379344018545,0.6251494370123678,
GRW2016_Ratio H/L normalized SILAC 1___1,,,
CF2017_FTE 17,,,0.4974343773559002
LY2019_P2-,,0.5743036724126418,
AH2018_LFQ_IT_1_X,0.3661134047130064,0.6411433452859294,
JJ2018_Ratio H/L normalized pP3___1,,,
RB2022_8_RecoveryStrength,,,
WZ2023_Pe_005_20min,0.34614928959879787,0.6400608848325157,0.4983093346115744
AST2020_Control.2,,,
NJH2025_Sub6_MICT_Mid,,,
RCJD2014_10min_1,,,
FSO2013_Ratio H/L normalized Rep2___3,,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,,
HS2024_3_I_T1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,,
CK2022_4 40-1,,0.6245822237298465,
SR2019_MCF10A_Biol_repl_4,,,
KS2014_Intensity pY_C5,,,
NJH2025_Sub4_MICT_Pre,,,
NJH2024_Sub9_MICT_Post,,,
CF2017_OSE 28,,,0.5034578683650852
HS2024_5_B_T2,,,
HS2024_6_I_T1,,,
HS2024_5_B_T3,,,
JJ2018_Ratio H/M normalized pP1___1,,,
KBE2022_Log2_Ex_36_U,0.27092412185409365,0.6223810987181629,
AH2018_TMTMS3_3_N,0.4083376311637599,0.6337200774833472,
SR2019_HCC1419_Biol_repl_2,,,
FR2021_Intensity.N,,,
AS2011_Ratio H/L Inhi_2_1,,,
AH2018_SILAC_MR_1_C,0.3648416759212967,0.6546209566024161,
NJH2024_Sub1_HIIT_Mid,,,
NJH2025_Sub8_HIIT_Mid,,,
EP2017_Mitotic R#3 log2 ratio,,,0.4887616778697677
KBE2022_Log2_Ex_36_T,0.2842819486304632,0.6285988214190393,
NJH2025_Sub6_HIIT_Mid,,,
WZ2023_Pu_005_30min,0.3664077551422155,0.6398422125046734,0.48371879262230394
KS2014_Intensity C2,,0.657363435586628,0.4944967909974061
FSO2013_Ratio H/L normalized Rep1___2,,,
RM2024_Intensity D2-2,,,
KBE2022_Log2_Ex_42_T,0.27092412185409365,0.6273255483442648,
CK2022_9 200-1,,0.6058511462432858,
GRW2016_Ratio H/L normalized SILAC 2___1,,,
JJ2018_Ratio H/M normalized pP3___2,,,
DB2022_LFQ intensity R1.1,,,
CK2022_10 200-1,,0.6037608093697692,
NJH2024_Sub9_MICT_Mid,,,
JAW2011_Ratio H/L_2,,,
HS2024_7_I_N2,,,
RBK2021_1332T Late,,,
LY2019_P1-,,0.5760846359876612,
RKK2015_TNF-α/basal.1,,,
RKK2015_TNF-α/TNF-α+SC-514,,,
CR2017_Ratio Replicate 2.5,0.3756339386245898,0.5859408469515086,
HS2024_3_I_T3,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,,
AS2011_Ratio H/L Normalized RNAi_1,,,
KS2014_Intensity E15_4,,0.6538890815917571,0.47669359359280666
ZQ2022_C3,,,
EJN2021_3_Rest_Ins,,,
YP2020_Intensity P10_R2_mult_log2,,,
MV2014_Ratio H/L normalized A1___3 (10 min),,,
NJH2025_Sub1_MICT_Pre,,,
KBE2022_Log2_Ex_39_T,0.30038301826590924,0.6256865509340435,
FSO2013_Ratio H/M normalized Rep3___2,,,
RM2024_Intensity D6-2,,,
EP2017_Untreated R#1 log2 ratio,,,0.5362140436595383
RKK2015_SC-514/basal,,,
RM2024_Intensity D6-1___3,,,
WZ2023_Pu_010_10min,0.3519567874834544,0.639270288066236,0.4905301258261712
NJH2025_Sub9_HIIT_Mid,,,
SR2019_SKBR3_Biol_repl_4,,0.5660463714435561,
HS2024_5_I_T3,,,
KS2014_Intensity N1,,0.6473894906807617,0.498112437928303
NJH2024_Sub12_MICT_Post,,,
TM2022_S2.8h.C,,,
CR2017_Ratio Replicate 1,0.3395081737269207,0.5984259633747208,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,,
JJ2018_Ratio H/M normalized pP3,,,
AH2018_SILAC_MR_2_C,0.33851877844136247,0.6545894557481016,
LATM2013_Log2 Ratio (Medium/Light) Forward,,,
PG2020_Intensity 2h_A,,0.586577556291927,
NJH2024_Sub6_MICT_Mid,,,
NJH2025_Sub13_HIIT_Post,,,
AH2018_SILAC_MR_3_X,0.3548432082489262,0.6535037688338033,
JJ2018_Ratio H/M normalized___1,,,
RCJD2014_15min_2,,,
AS2011_Ratio H/L_2,,,
AS2011_Ratio H/L Normalized,,,
RN2012_H03,,0.5722713525444129,
HS2024_5_B_N2,,,
HS2024_5_I_N1,,,
HS2024_6_I_N1,,,
AR2021_KD 48h,,0.6099083952253945,
FR2021_Intensity.B,,,
RB2022_3_PreEndurance,,,
HS2024_5_I_T1,,,
NJH2024_Sub10_MICT_Pre,,,
SR2019_LM2_Biol_repl_2,,,
AST2020_anti-CD3,,,
SR2019_MDAMB231_Biol_repl_1,,0.601908761682541,
RM2024_Intensity D2-3___3,,,
WZ2023_Pe_005_10min,0.35594343210880364,0.641084061392607,0.49692451967699475
KBE2022_Log2_Ex_29_U,0.2793124080070325,0.6302747679421413,
HS2024_7_B_T1,,,
AH2018_LFQ_M_2_X,0.3875561435391082,0.654900846742014,
AH2018_LFQ_IT_4_N,0.3473249417176752,0.6342380168767556,
CK2022_15 200-1,,0.6095457969434251,
RM2024_Intensity D4-1___2,,,
JJ2018_Ratio H/M normalized,,,
JJ2018_Ratio M/L normalized pP3___1,,,
KBE2022_Log2_Ex_34_T,0.29136438320187674,0.6263755393236828,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,,
LY2019_P2+,,0.6070193217973701,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,,
CK2022_2 200-1,,0.6084979523591914,
AS2011_Ratio H/L Protein RNAi_2,,,
MV2014_Ratio L/H normalized A3___1 (2 min),,,
WZ2023_Su_010_30min,0.360060829498547,0.6361928403343382,0.4817561842998381
RN2012_H01,,0.5851219442608476,
KTGR2014_Ratio-Rapa 2 mins,,,
EJN2021_2_Rest_Basal,,,
KS2014_Intensity pY_E5_3,,0.5932385317684128,
MM2018_Ratio H/L replicate 3,,0.5807218712757242,
EP2017_Pervanadate R#1 normalized log2 ratio,,,0.4446546447015293
HS2024_8_B_T3,,,
YA2020_Reporter_intensity_Cancer_No.3,0.3110792269185478,0.6132574869746008,
KBE2022_Log2_Ex_44_U,0.27092412185409365,0.6166296259272424,
WZ2023_Pe_010_20min,0.3554838744820089,0.6383780148558016,0.50253649087275
KS2014_Intensity pY_C6,,0.5940583610870864,
AS2011_Ratio H/L Normalized_3,,,
RCJD2014_15min_mean,,,
RB2022_3_PreStrength,,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,,
RCJD2014_10min_mean,,,
KS2014_Intensity C1,0.39205581728884764,0.657951861586531,0.4723863216878979
FSO2013_Ratio H/M normalized Rep3___1,,0.5863638512318341,0.4730302488596001
AH2018_SILAC_M_3_C,0.33627954357313744,0.640711678020743,
RKK2015_TNF-α+IKKb/TNF-α,,,
RM2024_Intensity D0-3___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,,
AH2018_SILAC_M_2_C,0.36097331559943474,0.6434247143056907,
AH2018_SILAC_M_2_X,0.3790513152492976,0.6439306231212776,
KTGR2014_Ratio-Rapa 15 mins,,,
RM2024_Intensity D4-2___1,,,
KBE2022_Log2_Ex_15_T,0.28952885686640367,0.6201452894692642,
VOI2024_0.1uM 24 h_1 di,,,
WZ2023_Su_010_10min,0.3624158910799494,0.6375652238082574,0.4846852447003653
PG2020_Intensity 6h_C,,0.6085968109780886,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,,
JJ2018_Ratio M/L normalized pP1___1,,,
AH2018_LFQ_M_3_N,0.37193179645467944,0.6551471207320878,
VOI2024_0.1uM 24 h_2 mono,,,
AH2018_TMTMS2_3_C,0.4085129812536363,0.6523539400251694,
CK2022_15 16-1,,0.6161230960817111,
CK2022_3 16-1,,0.6191324058913154,
LY2019_P4-,,0.5832279089445693,
FSO2013_Ratio H/L normalized Rep3___2,,,
KS2014_Intensity pY_PV2,,,
HS2024_3_I_N2,,,
GF2025_P8_Adh,,0.6180621327276885,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,,
GF2025_P5_Sph,,0.5906293375213725,
CK2022_10 16-1,,0.6211422277801661,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,,
VOI2024_0.1uM 2 h_2 di,,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,,
NJH2024_Sub2_HIIT_Mid,,,
AMK2021_45I_p3,,,
NJH2024_Sub13_HIIT_Mid,,,
DB2022_LFQ intensity R1.2,,,
DB2022_Intensity R1,,,
NJH2024_Sub12_MICT_Mid,,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,,
UK2020_HCM_4,,,
SAS2015_AZD/DMSO_Exp2,,,
IMM2018_normalised rep. int. CDK5L-1,,,
DB2022_LFQ intensity L2.2,,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,,
EP2017_Mitotic R#1 log2 ratio,,,0.48463616795038517
EJN2021_2_Ex_Basal,,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,,
KTGR2014_Ratio-Rapa 30 mins,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,,
CF2017_FTE 16,,,0.5019280169276408
AR2021_L41 10 μM,,0.5961659316501461,
CF2017_EOC 2,,,0.5176287716997858
RB2022_6_PostEndurance,,,
AH2018_SILAC_1_N,0.3754681564700264,0.6434239257176981,
NJH2024_Sub10_HIIT_Pre,,,
AS2011_Ratio H/L Inhi_1_2,,,
UK2020_HCM_6,,,
RB2022_7_PreSprint,,,
NJH2024_Sub2_MICT_Pre,,,
HS2024_3_PD_T2,,,
CK2022_6 16-1,,0.6141107445861369,
ZX2022_CB treated Replicate 1,,0.6246711649591461,
BS2014_Log2(Ratio H/L normalized Rep_3),,,
TM2022_mock.12h.C,,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,,
HH2022_Reporter intensity 0,,0.6126605293427225,
RM2024_Intensity D2-2___2,,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,,
RB2022_1_PreStrength,,,
JJ2018_Ratio H/M normalized pP2___2,,,
AH2018_TMTMS2_2_X,0.4215391646971679,0.6453362024184736,
AR2021_L41 1 μM,,0.5854880504783291,
JJ2018_Ratio H/M normalized pP1___2,,,
AH2018_TMTMS2_1_N,0.4168744363697928,0.645152927518492,
NJH2025_Sub10_MICT_Pre,,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,,
ZX2022_Control Replicate 3,,0.6241259273876347,
KS2014_Intensity C4,0.31185381427836506,0.6741921425636829,0.48556852123223754
AS2011_Ratio H/L Inhi_2,,,
KBE2022_Log2_Ex_18_T,0.2912390539296595,0.6243331045996999,
NJH2025_Sub9_MICT_Pre,,,
RCJD2014_20min_1,,,
MV2014_Ratio H/M normalized B2___1 (5 min),,,
FSO2013_Ratio M/L normalized Rep2___3,,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,,
SR2019_MCF10A_Biol_repl_3,,0.5711389499102487,
HS2024_7_B_T2,,,
SAS2015_PLX/DMSO_Exp3,,,
AMK2021_Ctrl_p5,,,
NJH2025_Sub2_HIIT_Mid,,,
AH2018_LFQ_M_3_C,0.3659316683981214,0.6521237545795816,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,,
YA2020_Reporter_intensity_Cancer_No.2,,0.603184789612448,
FSO2013_Ratio H/M normalized Rep2___3,,,
RB2022_8_PreSprint,,,
AH2018_SILAC_IT_3_C,0.37186296749117576,0.643966088120575,
WZ2023_Pu_025_10min,0.3610282785868742,0.638379980530942,0.49701249200913455
RM2024_Intensity D2-2___3,,,
AS2011_Ratio H/L_1,,,
RCJD2014_10min_3,,,
FSO2013_Ratio M/L normalized Rep3___1,,0.5876852813583473,0.4772385067690878
SR2019_JIMT1_Biol_repl_4,,0.5991195069108283,
YP2020_Intensity C10_R2_mult_log2,,,
ZCP2016_Ratio H/L Rep 2,,,
CF2017_EOC 4,,,0.5093926349335353
JJ2018_Ratio H/L normalized pP1___1,,,
WZ2023_Pe_010_30min,0.357346232670687,0.6396872613230176,0.4988282808716298
MV2014_Ratio L/M normalized B2___3 (30 min),,,
AH2018_LFQ_IT_3_N,0.38190313542744403,0.6381629238956126,
KS2014_Intensity C6,0.32560632674562673,0.6745676057192428,0.47449832212263443
ZQ2022_N3,,,
HW2015_Ratio H/L normalized Exp1,,,
CK2022_12 40-1,,0.6256155652915752,
NJH2024_Sub7_MICT_Pre,,,
ZX2022_Control Replicate 1,,0.628200665374182,
JJ2018_Ratio H/M normalized pP1,,,
CK2022_16 40-1,,0.6234582923783324,
AH2018_SILAC_IT_2_C,0.36287624806707913,0.6418446536067247,
CK2022_5 40-1,,0.6182595295252282,
AH2018_LFQ_3_X,0.3674455036038624,0.6506783515336324,
UK2020_UA_3,,,
LY2019_P7-,,0.5966221992315873,
GF2025_P5_Adh,,0.5849303573316722,
RB2022_1_PostStrength,,,
JAW2011_Ratio H/L LS1b,,,
FSO2013_Ratio H/L normalized Rep3___1,,0.5893681212653419,0.4909929128343969
SR2019_HCC1954_Biol_repl_3,,0.5722144188846001,
CR2017_Ratio Replicate 2.2,0.3619825072360572,0.5908124694444024,
VOI2024_0.1uM 2 h_1 mono,,,
MV2014_Ratio L/M normalized A2___1 (10 min),,,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,,
CK2022_11 16-1,,0.6187558838655643,
ZQ2022_C1,,,
CR2017_Ratio Replicate 2.1,0.3970771560868379,0.5794228908798134,
PG2020_Intensity CT_B,,0.5838568400735451,
JJ2018_Ratio M/L normalized___2,,,
AH2018_SILAC_MR_1_N,0.4125881187066808,0.6461147218611523,
KS2014_Intensity pY_E5_1,,0.5858888264953983,
JW2021_Before_3,,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,,
MV2014_Ratio M/H normalized B3___3 (30 min),,,
FS2019_db/db1,,,
NJH2025_Sub9_HIIT_Pre,,,
JAW2011_Ratio H/L_1,,,
RCJD2014_20min_3,,,
AH2018_LFQ_3_C,0.3482408480943565,0.6493688114851324,
JJ2018_Ratio M/L normalized pP3___2,,,
AMK2021_45I_p1,,,
NJH2025_Sub8_HIIT_Post,,,
AH2018_LFQ_M_3_X,0.37879522271195065,0.6538282573384246,
YA2020_Reporter_intensity_Cancer_No.4,0.27092412185409365,0.6051779540866262,
KS2014_Intensity pY_E5_2,,0.5933772910607923,
FSO2013_Ratio H/L normalized Rep1___3,,,
GF2025_P4_Sph,,0.585575820194058,
RB2022_2_PreEndurance,,,
JW2021_Before_1,,,
KBE2022_Log2_Ex_25_T,0.2794390279605511,0.6312459368867518,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,,
MV2014_Ratio L/M normalized A2___2 (10 min),,,
JJ2018_Ratio M/L normalized___1,,,
FR2021_Intensity.H,,,
CK2022_14 16-1,,0.6183885702786042,
AST2020_anti-CD3+PDL2,,,
MV2014_Ratio M/L normalized B1___1 (5 min),,,
KBE2022_Log2_Ex_19_T,,0.6137311261984046,
KS2014_Intensity pY_N1,,,0.49667530497708734
RB2022_1_RecoveryEndurance,,,
FSO2013_Ratio H/M normalized Rep1___2,,,
HS2024_8_I_T1,,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,,
EP2017_Mitotic R#2 log2 ratio,,,0.4618216279270469
AH2018_TMTMS2_1_X,0.4195611373966652,0.6485150637164441,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,,
ZCP2016_Ratio H/L Rep 3,,,
AS2011_Ratio H/L Normalized RNAi_1_3,,,
SR2019_MCF10A_Biol_repl_1,,0.57077378316273,
NJH2025_Sub8_MICT_Mid,,,
EJN2021_5_Ex_Ins,,,
HS2024_6_I_N2,,,
HH2022_Reporter intensity 4,,0.6010873644592576,
RBK2021_1326T Late,,,
TM2022_mock.12h.B,,,
NJH2024_Sub12_MICT_Pre,,,
RCJD2014_15min_3,,,
MV2014_Ratio L/H normalized B3___2 (5 min),,,
LG2023_Control-3_intensity,,,
JJ2018_Ratio H/L normalized pP3___2,,,
CF2017_FTE 15,,,0.49911675077498097
HS2024_4_I_T3,,,
AH2018_SILAC_1_X,0.3661260438152995,0.64123099853872,
PG2020_Intensity 10h_B,0.35130660762805643,0.5919595567966642,
AH2018_TMTMS3_1_X,0.3945360616252004,0.6290618254339961,
CF2017_FTE 14,,,0.48417076861999114
NJH2024_Sub13_HIIT_Post,,,
RM2024_Intensity D6-3___3,,,
NJH2025_Sub7_HIIT_Pre,,,
RBK2021_1259T Early,,,
RKK2015_IKK+TNF-α/IKKb,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,,
PG2020_Intensity 6h_A,,0.6121834772926646,
SR2019_HCC1419_Biol_repl_3,,0.5785484462906016,
KBE2022_Log2_Ex_14_T,,0.6158907112219556,
EP2017_Untreated R#2 normalized log2 ratio,,,0.48440298847811053
RM2024_Intensity D0-2___1,,,
DB2022_Intensity L1,,,
LY2019_P5+,,0.5947788857585261,
HS2024_5_I_N2,,,
SAS2015_PLX/AZD_Exp3,,,
EP2017_Pervanadate R#2 log2 ratio,,,0.4431553894566467
AS2011_Ratio H/L Normalized RNAi_2_1,,,
